Show simple item record

Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study

dc.contributor.authorCuline, Stephane
dc.contributor.authorCaty, Armelle
dc.contributor.authorDujardin, Charlotte
dc.contributor.authorAuclin, Edouard
dc.contributor.authorThibaut, Constance
dc.contributor.authorCombe, Pierre
dc.contributor.authorTartour, Eric
dc.contributor.authorOudard, Stephane
dc.contributor.authorGuven, Sermin
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorAuvray, Marie
dc.contributor.authorElaidi, Reza
dc.contributor.authorGauthier, Helene
dc.date.accessioned2021-03-06T20:31:52Z
dc.date.available2021-03-06T20:31:52Z
dc.date.issued2017
dc.identifier.citationAuvray M., Elaidi R., Ozguroglu M., Guven S., Gauthier H., Culine S., Caty A., Dujardin C., Auclin E., Thibaut C., et al., "Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study", CLINICAL GENITOURINARY CANCER, cilt.15, 2017
dc.identifier.issn1558-7673
dc.identifier.othervv_1032021
dc.identifier.otherav_fa9eee63-9d39-4491-9248-6fcafa086dcf
dc.identifier.urihttp://hdl.handle.net/20.500.12627/164089
dc.identifier.urihttps://doi.org/10.1016/j.clgc.2016.10.013
dc.description.abstractThis multicenter study assessed the prognostic value of the neutrophile-to-lymphocyte ratio (NLR), a biomarker of systemic inflammation, for overall survival (OS) and progression-free survival (PFS) after first-line chemotherapy (CT) in 280 metastatic urothelial cancer patients. High pre-CT NLR was an independent predictor of reduced of OS (hazard ratio=1.36; P<.0001), highlighting the importance of an inflammatory cancer-related microenvironment.
dc.language.isoeng
dc.subjectNefroloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titlePrognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study
dc.typeMakale
dc.relation.journalCLINICAL GENITOURINARY CANCER
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume15
dc.identifier.issue3
dc.contributor.firstauthorID243401


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record